In the global race against COVID-19, this Canadian company says it’s moving toward a treatment at ‘breakneck speed’
May 6, 2020
Excerpt from the article:
“VANCOUVER—A Canadian biotech company says it’s well on its way to developing a treatment for COVID-19 that could help save the lives of those most vulnerable to the virus.
And Carl Hansen’s AbCellera Biologics Inc. now has a $175-million vote of confidence from the federal government.”
Click the button below to read the article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?